Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China.

Chen XS, Yin YP, Wei WH, Wang HC, Peng RR, Zheng HP, Zhang JP, Zhu BY, Liu QZ, Huang SJ.

Clin Microbiol Infect. 2013 Oct;19(10):975-9. doi: 10.1111/1469-0691.12098. Epub 2012 Dec 10.

2.

Multicentre surveillance of prevalence of the 23S rRNA A2058G and A2059G point mutations and molecular subtypes of Treponema pallidum in Taiwan, 2009-2013.

Wu BR, Yang CJ, Tsai MS, Lee KY, Lee NY, Huang WC, Wu H, Lee CH, Chen TC, Ko WC, Lin HH, Lu PL, Chen YH, Liu WC, Yang SP, Wu PY, Su YC, Hung CC, Chang SY.

Clin Microbiol Infect. 2014 Aug;20(8):802-7. doi: 10.1111/1469-0691.12529. Epub 2014 Feb 13.

3.

High frequency of the 23S rRNA A2058G mutation of Treponema pallidum in Shanghai is associated with a current strategy for the treatment of syphilis.

Lu H, Li K, Gong W, Yan L, Gu X, Chai Z, Guan Z, Zhou P.

Emerg Microbes Infect. 2015 Feb;4(2):e10. doi: 10.1038/emi.2015.10. Epub 2015 Feb 11.

4.
5.

Jarisch-Herxheimer reaction among HIV-positive patients with early syphilis: azithromycin versus benzathine penicillin G therapy.

Tsai MS, Yang CJ, Lee NY, Hsieh SM, Lin YH, Sun HY, Sheng WH, Lee KY, Yang SP, Liu WC, Wu PY, Ko WC, Hung CC.

J Int AIDS Soc. 2014 Aug 28;17:18993. doi: 10.7448/IAS.17.1.18993. eCollection 2014.

6.

Azithromycin-resistant syphilis-causing strains in Sydney, Australia: prevalence and risk factors.

Read P, Jeoffreys N, Tagg K, Guy RJ, Gilbert GL, Donovan B.

J Clin Microbiol. 2014 Aug;52(8):2776-81. doi: 10.1128/JCM.00301-14. Epub 2014 May 21.

7.

Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China.

Martin IE, Gu W, Yang Y, Tsang RS.

Clin Infect Dis. 2009 Aug 15;49(4):515-21. doi: 10.1086/600878.

PMID:
19583516
8.

Treponema pallidum azithromycin resistance in Dublin, Ireland.

Muldoon EG, Walsh A, Crowley B, Mulcahy F.

Sex Transm Dis. 2012 Oct;39(10):784-6.

PMID:
23001265
9.

Molecular characterization of syphilis in patients in Canada: azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs.

Martin IE, Tsang RS, Sutherland K, Tilley P, Read R, Anderson B, Roy C, Singh AE.

J Clin Microbiol. 2009 Jun;47(6):1668-73. doi: 10.1128/JCM.02392-08. Epub 2009 Apr 1.

10.

Detection of the A2058G and A2059G 23S rRNA gene point mutations associated with azithromycin resistance in Treponema pallidum by use of a TaqMan real-time multiplex PCR assay.

Chen CY, Chi KH, Pillay A, Nachamkin E, Su JR, Ballard RC.

J Clin Microbiol. 2013 Mar;51(3):908-13. doi: 10.1128/JCM.02770-12. Epub 2013 Jan 2.

11.

Azithromycin resistance in Treponema pallidum.

Katz KA, Klausner JD.

Curr Opin Infect Dis. 2008 Feb;21(1):83-91. doi: 10.1097/QCO.0b013e3282f44772. Review.

PMID:
18192791
12.

Evaluation of azithromycin resistance in Treponema pallidum specimens from Madagascar.

Van Damme K, Behets F, Ravelomanana N, Godornes C, Khan M, Randrianasolo B, Rabenja NL, Lukehart S, Cohen M, Hook E.

Sex Transm Dis. 2009 Dec;36(12):775-6. doi: 10.1097/OLQ.0b013e3181bd11dd.

13.

Syphilis epidemiology in 1994-2013, molecular epidemiological strain typing and determination of macrolide resistance in Treponema pallidum in 2013-2014 in Tuva Republic, Russia.

Khairullin R, Vorobyev D, Obukhov A, Kuular UH, Kubanova A, Kubanov A, Unemo M.

APMIS. 2016 Jul;124(7):595-602. doi: 10.1111/apm.12541. Epub 2016 Apr 22.

PMID:
27102715
14.

Evaluation of macrolide resistance and enhanced molecular typing of Treponema pallidum in patients with syphilis in Taiwan: a prospective multicenter study.

Wu H, Chang SY, Lee NY, Huang WC, Wu BR, Yang CJ, Liang SH, Lee CH, Ko WC, Lin HH, Chen YH, Liu WC, Su YC, Hsieh CY, Wu PY, Hung CC.

J Clin Microbiol. 2012 Jul;50(7):2299-304. doi: 10.1128/JCM.00341-12. Epub 2012 Apr 18.

15.

Macrolide resistance testing and molecular subtyping of Treponema pallidum strains from southern Africa.

Müller EE, Paz-Bailey G, Lewis DA.

Sex Transm Infect. 2012 Oct;88(6):470-4. Epub 2012 May 18.

PMID:
22611234
16.

[Macrolide resistance in Treponema pallidum subsp. pallidum in the Czech Republic and in other countries].

Grillová L, Mikalová L, Zákoucká H, Židlická J, Šmajs D.

Epidemiol Mikrobiol Imunol. 2015 Mar;64(1):4-10. Czech.

PMID:
25872989
17.

Azithromycin resistance in Treponema pallidum.

Mabey D.

Sex Transm Dis. 2009 Dec;36(12):777-8. doi: 10.1097/OLQ.0b013e3181bd0fdd. No abstract available.

PMID:
19801961
18.

Two mutations associated with macrolide resistance in Treponema pallidum: increasing prevalence and correlation with molecular strain type in Seattle, Washington.

Grimes M, Sahi SK, Godornes BC, Tantalo LC, Roberts N, Bostick D, Marra CM, Lukehart SA.

Sex Transm Dis. 2012 Dec;39(12):954-8. doi: 10.1097/OLQ.0b013e31826ae7a8.

19.

Azithromycin treatment failure among primary and secondary syphilis patients in Shanghai.

Zhou P, Li K, Lu H, Qian Y, Gu X, Gong W, Tucker JD, Cohen MS.

Sex Transm Dis. 2010 Nov;37(11):726-9. doi: 10.1097/OLQ.0b013e3181e2c753.

20.

High Resistance to Azithromycin in Clinical Samples from Patients with Sexually Transmitted Diseases in Guangxi Zhuang Autonomous Region, China.

Zhu B, Bu J, Li W, Zhang J, Huang G, Cao J, Tang Z, Gan Q, Wei P.

PLoS One. 2016 Jul 28;11(7):e0159787. doi: 10.1371/journal.pone.0159787. eCollection 2016.

Supplemental Content

Support Center